A Clinical Study on Safety and Effectiveness of Mesenchymal Stem Cell Exosomes for the Treatment of COVID-19.

NCT05787288 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Pneumonia

Interventions

BIOLOGICAL: Extracellular Vesicles from Mesenchymal Stem Cells

Sponsor

First Affiliated Hospital of Wenzhou Medical University

Collaborators

[object Object]